Endogenous estradiol and the risk of incident fracture in postmenopausal women: The OPUS study

J. Finigan*, F. Gossiel, C. C. Glüer, D. Felsenberg, D. M. Reid, C. Roux, R. Eastell

*Corresponding author for this work

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Some, but not all, studies have found that low endogenous estradiol levels in postmenopausal women are predictive of fractures. The aim of this study was to examine the roles of endogenous estradiol (E 2), sex hormone binding globulin (SHBG), and dehydroepiandrosterone sulfate (DHEAS) in the prediction of incident vertebral and nonvertebral fractures. The study subjects were 797 postmenopausal women from the population-based OPUS (Osteoporosis and Ultrasound Study) study. Spine radiographs and dual-energy X-ray absorptiometry scans were obtained for all subjects at baseline and 6-year follow-up. Nonfasting blood samples were taken at baseline for E 2, SHBG, DHEAS, and bone turnover markers. Incident nonvertebral fractures were self-reported and verified; vertebral fractures were diagnosed at a single center from spinal radiographs. Medical and lifestyle data were obtained by questionnaire at each visit. Thirty-nine subjects had an incident vertebral fracture and 119 a nonvertebral fracture. Estradiol in the lowest quartile predicted vertebral fracture independent of confounders including age, body mass index, bone mineral density, bone turnover, fracture history, and use of antiresorptive therapy, with an OR of 2.97 (95 % confidence interval [CI] 1.52-5.82) by logistic regression. A calculated free estradiol index was not a stronger predictor than total E 2. Higher SHBG predicted vertebral fracture independently of age and body mass index, but not independently of E 2, bone mineral density, or prevalent fracture. Low DHEAS did not predict vertebral fracture. Nonvertebral fractures were not predicted by any of E 2, SHBG, or DHEAS, either in univariate or multivariate analyses. These findings suggest that there may be mechanistic differences in the protective effect of E 2 at vertebral compared with nonvertebral sites.

Original languageEnglish
Pages (from-to)59-68
Number of pages10
JournalCalcified Tissue International
Volume91
Issue number1
Early online date27 May 2012
DOIs
Publication statusPublished - Jul 2012

Fingerprint

Sex Hormone-Binding Globulin
Dehydroepiandrosterone Sulfate
Osteoporosis
Estradiol
Bone Remodeling
Bone Density
Body Mass Index
Bone Fractures
Photon Absorptiometry
Life Style
Spine
Multivariate Analysis
Logistic Models
Confidence Intervals
Population
Therapeutics

Keywords

  • Estradiol
  • Fracture prediction
  • Menopause
  • Metabolic bone diseases: clinical
  • Nonvertebral fractures
  • Osteoporosis: fractures
  • Phytoestrogens
  • Postmenopausal
  • SHBG
  • Steroid hormones: estrogens
  • Vertebral fractures

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Finigan, J., Gossiel, F., Glüer, C. C., Felsenberg, D., Reid, D. M., Roux, C., & Eastell, R. (2012). Endogenous estradiol and the risk of incident fracture in postmenopausal women: The OPUS study. Calcified Tissue International, 91(1), 59-68. https://doi.org/10.1007/s00223-012-9611-8

Endogenous estradiol and the risk of incident fracture in postmenopausal women : The OPUS study. / Finigan, J.; Gossiel, F.; Glüer, C. C.; Felsenberg, D.; Reid, D. M.; Roux, C.; Eastell, R.

In: Calcified Tissue International, Vol. 91, No. 1, 07.2012, p. 59-68.

Research output: Contribution to journalArticle

Finigan, J, Gossiel, F, Glüer, CC, Felsenberg, D, Reid, DM, Roux, C & Eastell, R 2012, 'Endogenous estradiol and the risk of incident fracture in postmenopausal women: The OPUS study', Calcified Tissue International, vol. 91, no. 1, pp. 59-68. https://doi.org/10.1007/s00223-012-9611-8
Finigan, J. ; Gossiel, F. ; Glüer, C. C. ; Felsenberg, D. ; Reid, D. M. ; Roux, C. ; Eastell, R. / Endogenous estradiol and the risk of incident fracture in postmenopausal women : The OPUS study. In: Calcified Tissue International. 2012 ; Vol. 91, No. 1. pp. 59-68.
@article{062b032ec43f45b9a21f64141146a110,
title = "Endogenous estradiol and the risk of incident fracture in postmenopausal women: The OPUS study",
abstract = "Some, but not all, studies have found that low endogenous estradiol levels in postmenopausal women are predictive of fractures. The aim of this study was to examine the roles of endogenous estradiol (E 2), sex hormone binding globulin (SHBG), and dehydroepiandrosterone sulfate (DHEAS) in the prediction of incident vertebral and nonvertebral fractures. The study subjects were 797 postmenopausal women from the population-based OPUS (Osteoporosis and Ultrasound Study) study. Spine radiographs and dual-energy X-ray absorptiometry scans were obtained for all subjects at baseline and 6-year follow-up. Nonfasting blood samples were taken at baseline for E 2, SHBG, DHEAS, and bone turnover markers. Incident nonvertebral fractures were self-reported and verified; vertebral fractures were diagnosed at a single center from spinal radiographs. Medical and lifestyle data were obtained by questionnaire at each visit. Thirty-nine subjects had an incident vertebral fracture and 119 a nonvertebral fracture. Estradiol in the lowest quartile predicted vertebral fracture independent of confounders including age, body mass index, bone mineral density, bone turnover, fracture history, and use of antiresorptive therapy, with an OR of 2.97 (95 {\%} confidence interval [CI] 1.52-5.82) by logistic regression. A calculated free estradiol index was not a stronger predictor than total E 2. Higher SHBG predicted vertebral fracture independently of age and body mass index, but not independently of E 2, bone mineral density, or prevalent fracture. Low DHEAS did not predict vertebral fracture. Nonvertebral fractures were not predicted by any of E 2, SHBG, or DHEAS, either in univariate or multivariate analyses. These findings suggest that there may be mechanistic differences in the protective effect of E 2 at vertebral compared with nonvertebral sites.",
keywords = "Estradiol, Fracture prediction, Menopause, Metabolic bone diseases: clinical, Nonvertebral fractures, Osteoporosis: fractures, Phytoestrogens, Postmenopausal, SHBG, Steroid hormones: estrogens, Vertebral fractures",
author = "J. Finigan and F. Gossiel and Gl{\"u}er, {C. C.} and D. Felsenberg and Reid, {D. M.} and C. Roux and R. Eastell",
year = "2012",
month = "7",
doi = "10.1007/s00223-012-9611-8",
language = "English",
volume = "91",
pages = "59--68",
journal = "Calcified Tissue International",
issn = "0171-967X",
publisher = "Springer New York",
number = "1",

}

TY - JOUR

T1 - Endogenous estradiol and the risk of incident fracture in postmenopausal women

T2 - The OPUS study

AU - Finigan, J.

AU - Gossiel, F.

AU - Glüer, C. C.

AU - Felsenberg, D.

AU - Reid, D. M.

AU - Roux, C.

AU - Eastell, R.

PY - 2012/7

Y1 - 2012/7

N2 - Some, but not all, studies have found that low endogenous estradiol levels in postmenopausal women are predictive of fractures. The aim of this study was to examine the roles of endogenous estradiol (E 2), sex hormone binding globulin (SHBG), and dehydroepiandrosterone sulfate (DHEAS) in the prediction of incident vertebral and nonvertebral fractures. The study subjects were 797 postmenopausal women from the population-based OPUS (Osteoporosis and Ultrasound Study) study. Spine radiographs and dual-energy X-ray absorptiometry scans were obtained for all subjects at baseline and 6-year follow-up. Nonfasting blood samples were taken at baseline for E 2, SHBG, DHEAS, and bone turnover markers. Incident nonvertebral fractures were self-reported and verified; vertebral fractures were diagnosed at a single center from spinal radiographs. Medical and lifestyle data were obtained by questionnaire at each visit. Thirty-nine subjects had an incident vertebral fracture and 119 a nonvertebral fracture. Estradiol in the lowest quartile predicted vertebral fracture independent of confounders including age, body mass index, bone mineral density, bone turnover, fracture history, and use of antiresorptive therapy, with an OR of 2.97 (95 % confidence interval [CI] 1.52-5.82) by logistic regression. A calculated free estradiol index was not a stronger predictor than total E 2. Higher SHBG predicted vertebral fracture independently of age and body mass index, but not independently of E 2, bone mineral density, or prevalent fracture. Low DHEAS did not predict vertebral fracture. Nonvertebral fractures were not predicted by any of E 2, SHBG, or DHEAS, either in univariate or multivariate analyses. These findings suggest that there may be mechanistic differences in the protective effect of E 2 at vertebral compared with nonvertebral sites.

AB - Some, but not all, studies have found that low endogenous estradiol levels in postmenopausal women are predictive of fractures. The aim of this study was to examine the roles of endogenous estradiol (E 2), sex hormone binding globulin (SHBG), and dehydroepiandrosterone sulfate (DHEAS) in the prediction of incident vertebral and nonvertebral fractures. The study subjects were 797 postmenopausal women from the population-based OPUS (Osteoporosis and Ultrasound Study) study. Spine radiographs and dual-energy X-ray absorptiometry scans were obtained for all subjects at baseline and 6-year follow-up. Nonfasting blood samples were taken at baseline for E 2, SHBG, DHEAS, and bone turnover markers. Incident nonvertebral fractures were self-reported and verified; vertebral fractures were diagnosed at a single center from spinal radiographs. Medical and lifestyle data were obtained by questionnaire at each visit. Thirty-nine subjects had an incident vertebral fracture and 119 a nonvertebral fracture. Estradiol in the lowest quartile predicted vertebral fracture independent of confounders including age, body mass index, bone mineral density, bone turnover, fracture history, and use of antiresorptive therapy, with an OR of 2.97 (95 % confidence interval [CI] 1.52-5.82) by logistic regression. A calculated free estradiol index was not a stronger predictor than total E 2. Higher SHBG predicted vertebral fracture independently of age and body mass index, but not independently of E 2, bone mineral density, or prevalent fracture. Low DHEAS did not predict vertebral fracture. Nonvertebral fractures were not predicted by any of E 2, SHBG, or DHEAS, either in univariate or multivariate analyses. These findings suggest that there may be mechanistic differences in the protective effect of E 2 at vertebral compared with nonvertebral sites.

KW - Estradiol

KW - Fracture prediction

KW - Menopause

KW - Metabolic bone diseases: clinical

KW - Nonvertebral fractures

KW - Osteoporosis: fractures

KW - Phytoestrogens

KW - Postmenopausal

KW - SHBG

KW - Steroid hormones: estrogens

KW - Vertebral fractures

UR - http://www.scopus.com/inward/record.url?scp=84863486910&partnerID=8YFLogxK

U2 - 10.1007/s00223-012-9611-8

DO - 10.1007/s00223-012-9611-8

M3 - Article

C2 - 22644322

AN - SCOPUS:84863486910

VL - 91

SP - 59

EP - 68

JO - Calcified Tissue International

JF - Calcified Tissue International

SN - 0171-967X

IS - 1

ER -